Akarsh Singh

Mr. Akarsh Singh

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2024 in Cancers
Verified
Journal Article
Open access
ABAadhi Aadhavan Balasubramanian
Aadhi Aadhavan Balasubramanian
SASalah Al-Heejawi
Salah Al-Heejawi
ASAkarsh Singh
Akarsh Singh
ABAnne C Breggia
Anne C Breggia
BABilal R Ahmad
Bilal R Ahmad
Saeed AmalSaeed Amal
Saeed Amal
Cancer diagnosis and classification are pivotal for effective patient management and treatment planning. In this study, a comprehensive approach is presented utilizing ensemble deep learning techniques to analyze breast cancer histopathology images. Our datasets were based on two widely employed datasets from different centers for two different tasks: BACH and BreakHis. Within the BACH dataset, a proposed ensemble strategy was employed, incorporating VGG16 and ResNet50 architectures to achieve precise classification of breast cancer histopathology images. Introducing a novel image patching technique to preprocess a high-resolution image facilitated a focused analysis of localized regions of interest. The annotated BACH dataset encompassed 400 WSIs across four distinct classes: Normal, Benign, In Situ Carcinoma, and Invasive Carcinoma. In addition, the proposed ensemble was used on the BreakHis dataset, utilizing VGG16, ResNet34, and ResNet50 models to classify microscopic images into eight distinct categories (four benign and four malignant). For both datasets, a five-fold cross-validation approach was employed for rigorous training and testing. Preliminary experimental results indicated a patch classification accuracy of 95.31% (for the BACH dataset) and WSI image classification accuracy of 98.43% (BreakHis). This research significantly contributes to ongoing endeavors in harnessing artificial intelligence to advance breast cancer diagnosis, potentially fostering improved patient outcomes and alleviating healthcare burdens.

30 November 2023 in Cancers
Verified
Journal Article
Open access
PDF file
ASAkarsh Singh
Akarsh Singh
SRShruti Milind Randive
Shruti Milind Randive
ABAnne C Breggia
Anne C Breggia
BABilal R Ahmad
Bilal R Ahmad
RCRobert Christman
Robert Christman
Saeed AmalSaeed Amal
Saeed Amal
Prostate cancer remains a significant cause of male cancer mortality in the United States, with an estimated 288,300 new cases in 2023. Accurate grading of prostate cancer is crucial for ascertaining disease severity and shaping treatment strategies. Modern deep learning techniques show promise in grading biopsies, but there is a gap in integrating these advances into clinical practice. Our web platform tackles this challenge by integrating human expertise with AI-driven grading, incorporating diverse data sources. We gathered feedback from four pathologists and one medical practitioner to assess usability and real-world alignment through a survey and the NASA TLX Usability Test. Notably, 60% of users found it easy to navigate, rating it 5.5 out of 7 for ease of understanding. Users appreciated self-explanatory information in popup tabs. For ease of use, all users favored the detailed summary tab, rating it 6.5 out of 7. While 80% felt patient demographics beyond age were unnecessary, high-resolution biopsy images were deemed vital. Acceptability was high, with all users willing to adopt the app, and some believed it could reduce workload. The NASA TLX Usability Test indicated a low–moderate perceived workload, suggesting room for improved explanations and data visualization.

27 March 2023
Verified
Conference Paper
Open access
ASAkarsh Singh
Akarsh Singh
MWMichael Wan
Michael Wan
LHLane Harrison
Lane Harrison
ABAnne C Breggia
Anne C Breggia
RCRobert Christman
Robert Christman
Saeed AmalSaeed Amal
Saeed Amal
The rise in Artificial Intelligence (AI) and deep learning research has shown great promise in diagnosing prostate cancer from whole slide image biopsies. Intelligent application interface for diagnosis is a progressive way to communicate AI results in the medical domain for practical use. This paper aims to suggest a way to integrate state-of-the-art deep learning algorithms into a web application for visualizations of decisions and analytics of an AI based algorithms applied on cancer digitized specimen biopsies. Performed primarily by visualizing evidence and explanation of the decision using image from the biopsy. By creating smart visualizations of tissue biopsy images, from magnified regions to augmented sharper images along with image masks that highlight cancerous regions of tissue in addition to intelligent analytics and distribution charts related to cancer prediction, we aim to communicate these easily interpretable results to assist pathologists in their workflow for grading prostate cancer biopsies and concerned medical team to make better decisions for prostate cancer diagnosis as case study

10 May 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
ABAadhi Aadhavan Balasubramanian
Aadhi Aadhavan Balasubramanian
SASalah Al-Heejawi
Salah Al-Heejawi
ASAkarsh Singh
Akarsh Singh
ABAnne C Breggia
Anne C Breggia
BABilal R Ahmad
Bilal R Ahmad
Saeed AmalSaeed Amal
Saeed Amal
Cancer diagnosis and classification are pivotal for effective patient management and treatment planning. In this study, we present a comprehensive approach utilizing ensemble deep learning techniques to analyze breast cancer histopathology images. Our datasets are based on two widely employed datasets from different centers for two different tasks: BACH and BreakHis. Within the BACH Dataset, we deployed an ensemble strategy incorporating VGG16 and ResNet50 architec-tures to achieve precise classification of breast cancer histopathology images. Introducing a novel image patching technique, to preprocess a high-resolution image, which facilitates focused analysis of localized regions of interest. The annotated BACH dataset encompasses 400 WSIs across four distinct classes: Normal, Benign, In Situ Carcinoma, and Invasive Carcinoma. In addition, we employed the BreakHis dataset, utilizing VGG16, ResNet34, and ResNet50 models to classify mi-croscopic images into eight distinct categories (four benign and four malignant). For both models we leveraged a five-fold cross-validation approach for rigorous training and testing. Preliminary ex-perimental results indicate a Patch classification accuracy of 95.31% (on BACH dataset) and WSI image classification accuracy of 98.43% (BreakHis). This research significantly contributes to on-going endeavors in harnessing artificial intelligence to advance breast cancer diagnosis, potentially fostering improved patient outcomes and alleviating healthcare burdens.

22 December 2022 in medRxiv
Verified
Preprint
Open access
PDF file
ASAkarsh Singh
Akarsh Singh
MWMichael Wan
Michael Wan
LHLane Harrison
Lane Harrison
ABAnne C Breggia
Anne C Breggia
RCRobert Christman
Robert Christman
Saeed AmalSaeed Amal
Saeed Amal
1 The rise in Artificial Intelligence (AI) and deep learning research has shown great promise in diagnosing prostate cancer from whole slide image biopsies. Intelligent application interface for diagnosis is a progressive way to communicate AI results in the medical domain for practical use. This paper aims to suggest a way to integrate state-of-the-art deep learning algorithms into a web application for visualizations of decisions and analytics of an AI based algorithms applied on cancer digitized specimen biopsies together with visualizing evidence and explanation of the decision using both image from the biopsy and textual data from Electronic Health Records (EHR). By creating smart visualizations of tissue biopsy images, from magnified regions to augmented sharper images along with image masks that highlight cancerous regions of tissue in addition to intelligent analytics and distribution charts related to cancer prediction, we aim to communicate these easily interpretable results to assist pathologists and concerned medical team to make better decisions for prostate cancer diagnosis as case study.